JGP Global Gestao de Recursos Ltda.
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 1, 2024), JGP Global Gestao de Recursos Ltda. reported 39 stock positions worth $51.1 million. Its top holding was New Gold (NGD) at 28.7% of the portfolio, followed by Stoneco Class A (STNE, 23.9%) and Rhythm Pharmaceuticals (RYTM, 5.8%). Compared with Q2 2024, it opened 10 new positions, sold out of 12, added to 19 and reduced 8. The biggest buy was New Gold (NGD, shares +4019%) and the biggest sale an exit from Nu Holdings Ltd./Cayman Isl-A (NU).
- Most Recent 13F
- Q3 2026
- Location
- RIO DE JANEIRO, D5
- CIK
- 0001536562
- Portfolio Value
- $51.1M (Q3 2024)
- SEC Filing
- 0001536562-24-000008 ↗ filed Nov 1, 2024
Holdings Value
Holdings 39 stocks · $51.1M
| NGD New Gold Inc. | 28.70% | 5,087,997 | $14.7M | Add +4018.9% |
| STNE Stoneco Ltd. Class A | 23.91% | 1,084,358 | $12.2M | Reduce -46.4% |
| RYTM Rhythm Pharmaceuticals Inc. | 5.78% | 56,378 | $3.0M | Add +869.7% |
| LLY Eli Lilly & Co. | 4.15% | 2,389 | $2.1M | Add +11.0% |
| ONC Beone Medicines Ltd.-ADR filed as BEIGENE LTD | 4.12% | 9,375 | $2.1M | Reduce -10.4% |
| INCY Incyte Corp. | 3.19% | 24,633 | $1.6M | Reduce -21.6% |
| UNH Unitedhealth Group Inc. | 2.59% | 2,262 | $1.3M | Reduce -5.8% |
| ITUB Itau Unibanco H-Spon PRF ADR | 2.58% | 197,897 | $1.3M | New |
| ISRG Intuitive Surgical Inc. | 1.86% | 1,932 | $949K | Add +9.5% |
| TMO Thermo Fisher Scientific Inc. | 1.72% | 1,423 | $880K | Add +2.5% |
| DHR Danaher Corp. | 1.35% | 2,474 | $688K | Add +32.9% |
| SYK Stryker Corp. | 1.32% | 1,864 | $673K | Add +10.4% |
| MRK Merck & Co. Inc. | 1.27% | 5,700 | $647K | Add +14.1% |
| ELV Elevance Health Inc. | 1.25% | 1,227 | $638K | Add +4.9% |
| REGN Regeneron Pharmaceuticals | 1.11% | 539 | $567K | Add +63.8% |
| ARGX Argenx SE - ADR | 1.06% | 1,003 | $544K | Add +13.1% |
| ACAD Acadia Pharmaceuticals Inc. | 1.04% | 34,620 | $532K | Reduce -5.8% |
| AEM Agnico Eagle Mines Ltd. | 1.03% | 6,497 | $523K | No change |
| VRTX Vertex Pharmaceuticals Inc. | 0.88% | 969 | $451K | Reduce -7.4% |
| AZN Astrazeneca PLC-Spons ADR | 0.88% | 5,768 | $449K | Add +24.6% |
| INSM Insmed Inc. | 0.88% | 6,123 | $447K | New |
| AMGN Amgen Inc. | 0.86% | 1,362 | $439K | Add +30.0% |
| ALNY Alnylam Pharmaceuticals Inc. | 0.83% | 1,548 | $426K | Add +25.6% |
| MDGL Madrigal Pharmaceuticals Inc. | 0.83% | 1,993 | $423K | Add +49.5% |
| SMMT Summit Therapeutics Inc. | 0.73% | 17,080 | $374K | New |
| RVMD Revolution Medicines Inc. | 0.68% | 7,706 | $349K | New |
| CI The Cigna Group | 0.62% | 912 | $316K | Add +43.4% |
| GDX Vaneck Gold Miners ETF | 0.61% | 7,871 | $313K | New |
| AGI Alamos Gold Inc. Class A | 0.60% | 15,452 | $308K | No change |
| BSX Boston Scientific Corp. | 0.59% | 3,608 | $302K | New |
| KYMR Kymera Therapeutics Inc. | 0.56% | 5,992 | $284K | New |
| NVO Novo-Nordisk A/S-Spons ADR | 0.51% | 2,171 | $259K | Add +31.7% |
| HCA HCA Healthcare Inc. | 0.46% | 583 | $237K | New |
| MOH Molina Healthcare Inc. | 0.41% | 608 | $209K | Reduce -20.9% |
| BPMC Blueprint Medicines Corp. | 0.40% | 2,204 | $204K | New |
| BDX Becton Dickinson and Co. | 0.40% | 841 | $203K | New |
| ABCL Abcellera Biologics Inc. | 0.12% | 22,598 | $59K | Add +27.1% |
| KOD Kodiak Sciences Inc. | 0.07% | 12,950 | $34K | Reduce -13.4% |
| CERS Cerus Corp. | 0.05% | 15,963 | $28K | Add +9.8% |
Options reported separately and not counted above: SGML puts ($175K).
Portfolio Sells Q2 2024 → Q3 2024
| NU Nu Holdings Ltd./Cayman Isl-A | Sold out | 0.00% | −20.11 |
| CUCSF China Communications Servi-H | Sold out | 0.00% | −16.03 |
| DSKYF Daiichi Sankyo Co. Ltd. | Sold out | 0.00% | −8.85 |
| STNE Stoneco Ltd. Class A | Reduce -46.4% | 23.91% | −6.89 |
| SPGI S&P Global Inc. | Sold out | 0.00% | −2.83 |
| LTHCF Lithium Ionic Corp. | Sold out | 0.00% | −0.48 |
| XOM Exxon Mobil Corp. | Sold out | 0.00% | −0.45 |
| BMRN Biomarin Pharmaceutical Inc. | Sold out | 0.00% | −0.44 |
| ROIV Roivant Sciences Ltd. | Sold out | 0.00% | −0.13 |
| BCRX Biocryst Pharmaceuticals Inc. | Sold out | 0.00% | −0.09 |
| SPINNOVA OYJ | Sold out | 0.00% | −0.07 |
| OI SA | Sold out | 0.00% | −0.00 |
| SBRCY Sberbank PJSC -Sponsored ADR | Sold out | 0.00% | 0.00 |
| KOD Kodiak Sciences Inc. | Reduce -13.4% | 0.07% | +0.02 |
| MOH Molina Healthcare Inc. | Reduce -20.9% | 0.41% | +0.12 |
| VRTX Vertex Pharmaceuticals Inc. | Reduce -7.4% | 0.88% | +0.26 |
| ACAD Acadia Pharmaceuticals Inc. | Reduce -5.8% | 1.04% | +0.28 |
| INCY Incyte Corp. | Reduce -21.6% | 3.19% | +0.77 |
| UNH Unitedhealth Group Inc. | Reduce -5.8% | 2.59% | +1.04 |
| ONC Beone Medicines Ltd.-ADR | Reduce -10.4% | 4.12% | +2.23 |
Portfolio Buys Q2 2024 → Q3 2024
| NGD New Gold Inc. | Add +4018.9% | 28.70% | +28.39 |
| RYTM Rhythm Pharmaceuticals Inc. | Add +869.7% | 5.78% | +5.48 |
| ITUB Itau Unibanco H-Spon PRF ADR | New | 2.58% | +2.58 |
| LLY Eli Lilly & Co. | Add +11.0% | 4.15% | +1.67 |
| INSM Insmed Inc. | New | 0.88% | +0.88 |
| ISRG Intuitive Surgical Inc. | Add +9.5% | 1.86% | +0.86 |
| DHR Danaher Corp. | Add +32.9% | 1.35% | +0.76 |
| TMO Thermo Fisher Scientific Inc. | Add +2.5% | 1.72% | +0.75 |
| SMMT Summit Therapeutics Inc. | New | 0.73% | +0.73 |
| RVMD Revolution Medicines Inc. | New | 0.68% | +0.68 |
| REGN Regeneron Pharmaceuticals | Add +63.8% | 1.11% | +0.67 |
| GDX Vaneck Gold Miners ETF | New | 0.61% | +0.61 |
| BSX Boston Scientific Corp. | New | 0.59% | +0.59 |
| SYK Stryker Corp. | Add +10.4% | 1.32% | +0.59 |
| ARGX Argenx SE - ADR | Add +13.1% | 1.06% | +0.58 |
| KYMR Kymera Therapeutics Inc. | New | 0.56% | +0.56 |
| MRK Merck & Co. Inc. | Add +14.1% | 1.27% | +0.48 |
| HCA HCA Healthcare Inc. | New | 0.46% | +0.46 |
| ALNY Alnylam Pharmaceuticals Inc. | Add +25.6% | 0.83% | +0.45 |
| ELV Elevance Health Inc. | Add +4.9% | 1.25% | +0.44 |
| AMGN Amgen Inc. | Add +30.0% | 0.86% | +0.44 |
| AZN Astrazeneca PLC-Spons ADR | Add +24.6% | 0.88% | +0.42 |
| BPMC Blueprint Medicines Corp. | New | 0.40% | +0.40 |
| BDX Becton Dickinson and Co. | New | 0.40% | +0.40 |
| MDGL Madrigal Pharmaceuticals Inc. | Add +49.5% | 0.83% | +0.35 |
| CI The Cigna Group | Add +43.4% | 0.62% | +0.35 |
| NVO Novo-Nordisk A/S-Spons ADR | Add +31.7% | 0.51% | +0.21 |
| ABCL Abcellera Biologics Inc. | Add +27.1% | 0.12% | +0.05 |
| CERS Cerus Corp. | Add +9.8% | 0.05% | +0.02 |
Options Activity Q2 2024 → Q3 2024
| SGML Sigma Lithium Corp. | put | New | 5,000 | $175K |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q3 2026 | 24 | $48.3M | XP, IAUX, SPY, PROSY, LLY |
| Q2 2026 | 29 | $44.8M | XP, SPY, SFTBY, VEON, PROSY |
| Q1 2026 | 23 | $22.3M | STNE, XP, NU, LLY, ABBV |
| Q4 2025 | 44 | $168.9M | NGD, STNE, SOLS, RRC, NU |
| Q3 2025 | 32 | $171.4M | NGD, STNE, XP, NU, ONC |
| Q2 2025 | 45 | $204.3M | STNE, NGD, XP, KTOS, IBIT |
| Q1 2025 | 34 | $130.7M | STNE, NGD, PPLT, XP, CAPRI HOLDINGS LTD |
| Q4 2024 | 39 | $43.9M | NGD, STNE, LLY, ONC, INCY |
| Q3 2024 | 39 | $51.1M | NGD, STNE, RYTM, LLY, ONC |
| Q2 2024 | 41 | $78.8M | STNE, NU, CUCSF, DSKYF, SPGI |
| Q1 2024 | 58 | $155.5M | BYDDF, XP, STNE, NU, NGD |